Poietis
Laser-assisted bioprinting systems for research laboratories and clinical tissue manufacturers
Highlights
- New on EvolcAdded 2026-10-30
About Poietis
Poietis Biosystems designs and builds laser-assisted bioprinting instruments, software, and application know-how for tissue engineering. Its NGB-R research platform and NGB-C clinical platform combine laser and bioextrusion to print cells, hydrogels, and spheroids.
The systems serve research laboratories and clinical manufacturers working on tissue models, organ-on-chip, skin substitutes, drug discovery, and regenerative medicine. The company is based in Pessac, in the Bordeaux metropolitan area, and was founded in 2014.
Product: NGB-R research and NGB-C clinical bioprinting systems, along with software and application know-how.
Public tenders won
1 tender won since 1 Jan 2024 from 1 public buyer in Italy, worth €300k as awarded. From EU award notices (TED) that name Poietis by its registry number.
- 29 Mar 2024 Università degli Studi "G. d'Annunzio" Chieti-Pescara · Procedura negoziata senza previa pubblicazione di un bando di gara, ai sensi dell’art.63 comma 2, lett. b) punti 2) e 3) del D. L.vo n.50/2016, con unico fornitore per la fornitura di una Biostampante digitale NGB-R Multi-modal 4D Bioprinting Platform. CIG: 9725650446 · €300k notice
Jobs at Poietis
Leadership
- Fabien Guillemot · Poietis FounderSource: company website
- Laurent Vrignaud · General ManagerSource: company website
More biotech & pharma companies
Promise Proteomics
Mass spectrometry protein and monoclonal antibody quantification products for clinical and bioanalytical laboratoriesNew on EvolcProteogenix
Antibody discovery, engineering and early-development services for biotech, pharmaceutical, diagnostic, veterinaryNew on EvolcProvepharm
Develops medical dyes for healthcare professionals performing precision surgery and clinical proceduresNew on EvolcQubit Pharmaceuticals
Develops AI- and quantum-enabled drug discovery tools and therapeutics for pharmaceutical partners and patients with major diseasesNew on EvolcRoowin
Fine chemistry and cGMP drug-development services for pharmaceutical, biotechnology, and fine chemical companiesNew on EvolcScreencell
Patented CTC isolation kits that enrich circulating tumor cells from whole blood for cancer researchers and laboratoriesNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Apache
- Google Tag Manager
- WordPress